$ cat ./records/malaria-deaths-reduced-by-more-than-60-since-2000-through-gates-b-2023.txt
Malaria deaths reduced by more than 60% since 2000 through Gates-backed programs
[RECORD.TXT] · cat --full
Over the 23 years from 2000 to 2023, malaria deaths fell by more than 60% globally, with 2.2 billion cases and 12.7 million deaths averted. Gates Foundation funding of the Global Fund, insecticide-treated bed nets, artemisinin combination therapies, and the first and second WHO-approved malaria vaccines contributed significantly to these gains. Gates has described malaria eradication as achievable within the next 20 years and has committed the Foundation to staying the course despite global funding headwinds.
Source: https://www.gatesfoundation.org/our-work/programs/global-health/malaria
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Committed $40 million to advance mRNA vaccine manufacturing in Africa and globally
Next →
Child mortality cut in half globally during the Gates Foundation's first 25 years
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.